Abstract
THE current treatment of subacute bacterial endocarditis requires the intramuscular administration of large amounts of penicillin. Although this route is generally well tolerated, pain and inflammation at local sites of injection can become a significant problem in the management of certain patients. Because of low and unpredictable serum levels attained after oral administration of penicillin G, effective oral therapy has not previously been available.Recent studies on phenoxymethyl penicillin (penicillin V) have suggested that this agent may represent a better means of oral administration. This compound is stable and relatively insoluble at pH ranges below 3.0. It is readily converted . . .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
